Aeterna Zentaris Inc.(Toronto Stock Exchange : AEZS)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -1.05% | 87.30 | 1.3% | $1275.26m | |
| AMGN | Amgen Inc. | -0.25% | 198.89 | 1.2% | $667.61m | |
| GILD | Gilead Sciences, Inc. | -1.28% | 67.64 | 0.9% | $577.79m | |
| BIIB | Biogen Inc. | -1.63% | 332.03 | 1.3% | $485.41m | |
| LOXO | Loxo Oncology Inc | -0.18% | 233.26 | 12.7% | $449.60m | |
| ILMN | Illumina, Inc. | 0.05% | 305.63 | 3.5% | $350.96m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.28% | 186.15 | 1.9% | $318.23m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.12% | 404.54 | 2.6% | $308.69m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.03% | 111.70 | 2.0% | $229.47m | |
| TSRO | TESARO, Inc. | 0.03% | 74.88 | 14.4% | $201.67m | |
| A | Agilent Technologies, Inc. | -0.82% | 70.02 | 1.5% | $164.25m | |
| EXAS | Exact Sciences Corporation | -2.75% | 74.97 | 25.3% | $151.07m | |
| INCY | Incyte Corporation | -2.79% | 76.56 | 2.5% | $146.84m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.45% | 119.26 | 15.4% | $142.24m | |
| LGND | Ligand Pharmaceuticals Incorporated | -16.48% | 110.05 | 23.1% | $105.44m |
Company Profile
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. It operates through biopharmaceutical segment. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Charleston, SC.